XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Total Global Payments Shareholders’ Equity
Number of Shares
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Nonredeemable Noncontrolling Interests
Total Equity
Balance at beginning of period (in shares) at Dec. 31, 2022     263,082,000          
Balance at beginning of period at Dec. 31, 2022   $ 22,303,506   $ 19,978,095 $ 2,731,380 $ (405,969) $ 236,704 $ 22,540,210
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (4,420) (11,041)     (11,041)   6,621 (4,420)
Other comprehensive loss $ 1,526 (4,848)       (4,848) 6,374 1,526
Stock issued under share-based compensation plans (in shares)     1,014,000          
Stock issued under share-based compensation plans   6,103   6,103       6,103
Common stock repurchased - share-based compensation plans (in shares)     (266,000)          
Common stock repurchased - share-based compensation plans   (30,189)   (30,189)       (30,189)
Share-based compensation expense   89,566   89,566       89,566
Issuance of share-based awards in connection with a business combination   2,484   2,484       2,484
Repurchase of common stock (in shares) (2,058,902)   (2,059,000)          
Repurchases of common stock $ (206,600) (206,553)   (206,553)       (206,553)
Distributions to noncontrolling interests             (6,218) (6,218)
Cash dividends declared   (65,750)     (65,750)     (65,750)
Balance at end of period (in shares) at Mar. 31, 2023     261,771,000          
Balance at end of period at Mar. 31, 2023   22,083,278   19,839,506 2,654,589 (410,817) 243,481 22,326,759
Redeemable Noncontrolling Interests                
Redeemable noncontrolling interests acquired in a business combination 556,070              
Ending balance at Mar. 31, 2023 556,070              
Balance at beginning of period (in shares) at Dec. 31, 2023     260,383,000          
Balance at beginning of period at Dec. 31, 2023 23,279,550 22,999,210   19,800,953 3,457,182 (258,925) 280,340 23,279,550
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 323,062 313,307     313,307   7,693 321,000
Other comprehensive loss $ (61,600) (38,513)       (38,513) (15,001) (53,514)
Stock issued under share-based compensation plans (in shares)     1,132,000          
Stock issued under share-based compensation plans   11,031   11,031       11,031
Common stock repurchased - share-based compensation plans (in shares)     (322,000)          
Common stock repurchased - share-based compensation plans   (42,663)   (42,663)       (42,663)
Share-based compensation expense   40,117   40,117       40,117
Repurchase of common stock (in shares) (6,061,999)   (6,062,000)          
Repurchases of common stock $ (808,400) (808,365)   (808,365)       (808,365)
Distributions to noncontrolling interests             (4,748) (4,748)
Contributions from noncontrolling interests             89 89
Reclassification of redeemable noncontrolling interest to nonredeemable noncontrolling interest             358,872 358,872
Purchase of capped calls related to issuance of convertible notes, net of taxes of $61,573   (194,677)   (194,677)       (194,677)
Cash dividends declared   (63,616)     (63,616)     (63,616)
Balance at end of period (in shares) at Mar. 31, 2024     255,131,000          
Balance at end of period at Mar. 31, 2024 22,843,076 $ 22,215,831   $ 18,806,396 $ 3,706,873 $ (297,438) $ 627,245 $ 22,843,076
Beginning balance at Dec. 31, 2023 507,965              
Redeemable Noncontrolling Interests                
Net income 2,062              
Other comprehensive loss (8,086)              
Reclassification of redeemable noncontrolling interest to nonredeemable noncontrolling interest (358,872)              
Ending balance at Mar. 31, 2024 $ 143,069